Xebra Brands Ltd. (XBRAF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerXebra Brands Ltd. (XBRAF) trades at $0.0001. Xebra Brands Ltd. is a Canadian cannabis company focused on developing and distributing cannabis-infused beverages and wellness products. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for XBRAF: XBRAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Xebra Brands Ltd. (XBRAF) Healthcare & Pipeline Overview
Xebra Brands Ltd. cultivates, processes, manufactures, and distributes cannabis products in Canada, focusing on cannabis-infused beverages and wellness products. Operating under brands like HighJack and MadCap, Xebra targets the evolving Canadian cannabis market amidst increasing competition and regulatory changes, with a current market capitalization of $0.00B.
What Is the Investment Thesis for XBRAF?
Xebra Brands Ltd. operates in the high-growth Canadian cannabis market, with a focus on cannabis-infused beverages and wellness products. Key value drivers include the expansion of its branded product lines (HighJack, MadCap) and penetration into new Canadian markets. The company's negative profit margin of -1831.8% and gross margin of -288.6% indicate significant challenges in achieving profitability. Growth catalysts include potential regulatory changes favoring cannabis-infused products and successful product innovation. However, the company faces risks related to intense competition, regulatory uncertainties, and the need for substantial capital to scale operations. Investors should closely monitor Xebra's ability to improve its financial performance and gain market share in the competitive cannabis industry.
Based on FMP financials and quantitative analysis
XBRAF Key Highlights
Market Cap of $0.00B reflects the company's current valuation in the market.
- P/E Ratio of -0.14 indicates the company is currently not profitable.
- Profit Margin of -1831.8% highlights significant challenges in achieving profitability.
- Gross Margin of -288.6% suggests substantial costs associated with producing and selling its products.
- Beta of -1.90 indicates the stock price is negatively correlated with the market, potentially offering diversification benefits.
Who Are XBRAF's Competitors?
XBRAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TAK Takeda Pharmaceutical Company Limited | $17.86 | 0.00% | $56.8B | — |
| TEVA Teva Pharmaceutical Industries Limited | $39.53 | +0.56% | $46.0B | — |
| HLN Haleon plc | $8.80 | +0.92% | $38.8B | — |
| ZTS Zoetis Inc. | $69.69 | +0.85% | $29.2B | — |
| VTRS Viatris Inc. | $17.60 | +0.80% | $20.5B | — |
| ELAN Elanco Animal Health Incorporated | $22.14 | +1.70% | $11.1B | — |
| RDY Dr. Reddy's Laboratories Limited | $12.25 | 0.00% | $10.2B | — |
| LNTH Lantheus Holdings, Inc. | $99.96 | +0.31% | $6.51B | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are XBRAF's Key Strengths?
Established brands in the cannabis beverage market.
- Diverse product portfolio including beverages and wellness products.
- Operations in the rapidly growing Canadian cannabis market.
- Expertise in cannabis cultivation, processing, and manufacturing.
What Are XBRAF's Weaknesses?
Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Dependence on regulatory approvals and changes.
- Need for significant capital investment to scale operations.
What Are the Key Risks for XBRAF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from established cannabis companies.
- Regulatory uncertainties and changes in the Canadian cannabis market.
- Fluctuations in cannabis prices and demand.
- Negative profit margin and gross margin impacting financial sustainability.
What Are XBRAF's Competitive Advantages?
- Brand recognition through established brands like HighJack and MadCap.
- Proprietary formulations for cannabis-infused beverages and wellness products.
- Established distribution network in select Canadian markets.
- Expertise in cannabis cultivation, processing, and manufacturing.
What Does XBRAF Do?
Xebra Brands Ltd., established in 2019 and headquartered in Vancouver, Canada, is a cannabis company focused on the cultivation, processing, manufacturing, design, and delivery of cannabis products. The company's primary focus is on cannabis-infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks. Additionally, Xebra Brands offers wellness products such as capsules, tinctures, topicals, and intimate oils for personal care. Xebra Brands operates under several brands, including HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle. These brands cater to different consumer preferences and market segments within the cannabis industry. The company aims to establish a strong presence in the Canadian cannabis market by offering a diverse product portfolio and focusing on innovation and quality. Since its inception, Xebra Brands has been navigating the evolving regulatory landscape of the Canadian cannabis industry. The company's strategy involves developing and marketing products that comply with Canadian regulations while meeting consumer demand for innovative cannabis products. Xebra Brands faces competition from established players in the cannabis industry, as well as new entrants, requiring a focus on brand differentiation and efficient operations to succeed.
What Products and Services Does XBRAF Offer?
- Cultivates cannabis plants.
- Processes raw cannabis into various forms.
- Manufactures cannabis-infused beverages.
- Produces cannabis wellness products like capsules and tinctures.
- Designs product packaging and branding.
- Distributes cannabis products to retailers in Canada.
How Does XBRAF Make Money?
- Cultivation and processing of cannabis.
- Manufacturing and distribution of branded cannabis products.
- Sales through retail channels and partnerships.
- Revenue generation from product sales.
What Industry Does XBRAF Operate In?
Xebra Brands operates within the Canadian cannabis industry, which is experiencing rapid growth and evolving regulatory frameworks. The market includes both recreational and medicinal cannabis products, with increasing demand for cannabis-infused beverages and wellness products. Competition is intense, with numerous companies vying for market share. Key trends include product innovation, regulatory changes, and increasing consumer acceptance of cannabis. Xebra Brands must navigate these trends and competitive pressures to establish a sustainable market position.
Who Are XBRAF's Key Customers?
- Recreational cannabis consumers in Canada.
- Wellness-focused individuals seeking cannabis-based products.
- Retailers and distributors of cannabis products.
- Consumers interested in cannabis-infused beverages.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Xebra Brands Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Rodrigo Valencia Gallardo. XBRAF has traded publicly since 2021.
Financial Health
Xebra Brands Ltd.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
XBRAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
XBRAF Latest News
No recent news available for XBRAF.
XBRAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for XBRAF.
Price Targets
Wall Street price target analysis for XBRAF.
XBRAF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for XBRAF; grades run from A+ (80-100) to F (below 30).
Leadership: Rodrigo Valencia Gallardo
CEO
Rodrigo Valencia Gallardo is the Chief Executive Officer of Xebra Brands Ltd. His background includes experience in business development, strategic planning, and operations management. He has held various leadership positions in the consumer goods and cannabis industries. His expertise lies in driving growth, building strong teams, and executing strategic initiatives. He is responsible for overseeing all aspects of Xebra Brands' operations, including cultivation, processing, manufacturing, and distribution.
Track Record: Under Rodrigo Valencia Gallardo's leadership, Xebra Brands has focused on expanding its product portfolio and market presence in the Canadian cannabis market. Key milestones include the launch of new cannabis-infused beverage brands and the development of innovative wellness products. He has also focused on building strategic partnerships and strengthening the company's distribution network. His leadership is aimed at positioning Xebra Brands for long-term growth and success in the competitive cannabis industry.
XBRAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Xebra Brands Ltd. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with higher risk profiles and speculative ventures.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Lower liquidity and potential for price volatility.
- Higher risk of fraud or mismanagement.
- Potential for delisting or trading suspension.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's financial reporting status and access available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available independent research reports or analyst opinions.
- Check for any regulatory filings or legal proceedings.
- Monitor trading volume and price volatility.
- Understand the risks associated with investing in OTC stocks.
- Established brands in the cannabis beverage market.
- Operations in the rapidly growing Canadian cannabis market.
- Experienced management team with industry expertise.
- Focus on regulatory compliance and product quality.
- Partnerships with reputable distributors and retailers.
What Investors Ask About Xebra Brands Ltd. (XBRAF) — Healthcare
What do analysts say about XBRAF stock?
As of 2026-03-17, there is no readily available analyst consensus on XBRAF stock due to its OTC listing and limited coverage. Key valuation metrics such as the P/E ratio (-0.14) and negative profit margin (-1831.8%) indicate that the company is currently not profitable.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or inconsistent.